Colorectal Cancer Incidence and Mortality in China, 2010

  • Zheng, Zhao-Xu (Cancer Hospital and Institute, Chinese Academy of Medical Sciences) ;
  • Zheng, Rong-Shou (National Office for Cancer Prevention and Control, National Cancer Center) ;
  • Zhang, Si-Wei (National Office for Cancer Prevention and Control, National Cancer Center) ;
  • Chen, Wan-Qing (National Office for Cancer Prevention and Control, National Cancer Center)
  • Published : 2014.10.23


Background: The National Central Cancer Registry of China (NCCR) affiliated to the Bureau of Disease Control, National Health and Family Planning Commission of China is responsible for cancer surveillance in the entire country. Cancer registration data from each local registry located in each province are collected by NCCR annually to be analyzed and published to provide useful information for policy makers and cancer researchers. Materials and Methods: Until 1st June, 2013, 219 population-based cancer registries submitted data of 2010 to the National Central Cancer Registry of China covering about 207,229,403 population, and 145 cancer registries were selected after quality evaluation for this study. Colorectal cancer cases were selected from the database according to ICD-10 coded as "C18-C20". We calculated the crude incidence and mortality rates by sex, age groups and location (urban/rural). The China population in 2000 and Segi's population were used as standardized populations for the calculation of age-standardized rates. The 6th National Population Census data of China was used to combined with the cancer registries' data to estimate the colorectal cancer burden in China in 2010. Results: Colorectal cancer was the sixth most common cancer in China. It was estimated that there were 274,841 new cases diagnosed in 2010 (157,355 in males and 117,486 in females), with the crude incidence rate of 20.1/100,000, highest in males in urban areas. Age-standardized rates by China standard population of 2000 (ASRcn) and World standard population (Segi's population, ASRwld) for incidence were 16.1/100,000 and 15.9/100,000 respectively. There were 132,110 cases estimated to have died from colorectal cancer in China in 2010 (76,646 men and 55,464 women) with the crude mortality rate of 10.1/100,000. The ASRcn and ASRwld for mortality were 7.55/100,000 and 7.44/100,000 respectively, higher in males and urban areas than in females and rural areas. The incidence and mortality rates increased with age, reaching peaksin the 80-84 year old, and oldest age groups, respectively. Conclusions: Colorectal cancer is one of the most common incident cancers and cause of cancer death in China. Primary and secondary prevention, with attention to a health lifestyle, physical activity and screening should be enhanced in the general population.


Colorectal cancer;incidence;mortality;China


  1. Atkin WS, Edwards R, Kralj-Hans I, et al (2010). Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet, 375, 1624-33.
  2. Bardou M, Barkun AN, Martel M (2013). Obesity and colorectal cancer. Gut, 62, 933-47.
  3. Dai Z, Xu YC, Niu L (2007). Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World J Gastroenterol, 13, 4199-206.
  4. Baxter NN, Goldwasser MA, Paszat LF, et al (2009). Association of colonoscopy and death from colorectal cancer. Ann Intern Med, 150, 1-8.
  5. Citarda F, Tomaselli G, Capocaccia R, et al (2001). Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut, 48, 812-5.
  6. CuradoMPE B, Shin HR, Storm H, et al (2007). Cancer Incidence in Five Continents, Vol. IX.IARC Scientific Publications No. 160, Lyon, IARC.
  7. Ferlay J, Burkhard C, Whelan S, Parkin DM (2005). Check and conversion programs for cancer registries.
  8. Ferlay J, Shin HR, Bray F, et al (2008). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
  9. Guh DP, Zhang W, Bansback N, et al (2009). The incidence of comorbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health, 9, 88.
  10. Harriss DJ, Atkinson G, George K, et al (2009). Lifestyle factors and colorectal cancer risk (1): systematic review and metaanalysis of associations with body mass index. Colorectal Dis, 11, 547-63.
  11. Hoff G, Grotmol T, Skovlund E, Bretthauer M (2009). Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ, 338, 1846.
  12. Ibfelt EH, Kjaer SK, Hogdall C, et al (2013). Socioeconomic position and survival after cervical cancer: influence of cancer stage, comorbidity and smoking among Danish women diagnosed between 2005 and 2010. Br J Cancer, 109, 2489-95.
  13. Manser CN, Bauerfeind P (2014). Impact of socioeconomic status on incidence, mortality, and survival of colorectal cancer patients: a systematic review. Gastrointest Endosc, 80, 42-60.
  14. Johnson CM, Wei C, Ensor JE, et al (2013). Meta-analyses of colorectal cancer risk factors. Cancer Causes Control, 24, 1207-22.
  15. Levi Z, Kark JD, Shamiss A, et al (2013). Body mass index and socioeconomic status measured in adolescence, country of origin, and the incidence of gastroesophageal adenocarcinoma in a cohort of 1 million men. Cancer, 119, 4086-93.
  16. Manser CN, Bachmann LM, Brunner J, et al (2012). Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study. Gastrointest Endosc, 76, 110-7.
  17. Menvielle G, Rey G, Jougla E, Luce D (2013). Diverging trends in educational inequalities in cancer mortality between men and women in the 2000s in France. BMC Public Health, 13, 823.
  18. Morris R, Carstairs V (1991). Which deprivation? A comparison of selected deprivation indexes. J Public Health Med, 13, 318-26.
  19. National Office for Cancer Prevention and Control, National center for cancer registry, disease prevnetion and control bureau, moh. Chinese cancer registry annual report (2010). military medical science press. Beijing 2011; 2.
  20. OECD Health at a Glance 2011: OECD Indicators, OECD Publishing. Available at: 2011. Accessed June 4, 2013.
  21. Parise CA, Caggiano V (2013). Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000-2010. BMC Cancer, 13, 449.
  22. Parkin DM (1994). Comparability and quality control in cancer registration: IARC).
  23. Zauber AG, Winawer SJ, O'Brien MJ, et al (2012). Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med, 366, 687-96.
  24. Singh H, Nugent Z, Demers AA, et al (2010). The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology, 139, 1128-37.
  25. Weiderpass E, Pukkala E (2006). Time trends in socioeconomic differences in incidence rates of cancers of gastro-intestinal tract in Finland. BMC Gastroenterol, 6, 41.
  26. Winawer SJ, Zauber AG, Ho MN, et al (1993). Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med, 329, 1977-81.

Cited by

  1. Secondary Circulating Tumor Cells (CTCs) but not Primary CTCs are Associated with the Clinico-Pathological Parameters in Chilean Patients With Colo-Rectal Cancer vol.16, pp.11, 2015,
  2. Increasing Incidence of Colorectal Cancer, Starting at a Younger Age for Rectal Compared to Colon Cancer in Brunei Darussalam vol.16, pp.12, 2015,
  3. Mechanistic Studies of Cyclin-Dependent Kinase Inhibitor 3 (CDKN3) in Colorectal Cancer vol.16, pp.3, 2015,
  4. Clustering Asian and North African Countries According to Trend of Colon and Rectum Cancer Mortality Rates: an Application of Growth Mixture Models vol.16, pp.9, 2015,
  5. A multi-center randomized phase II clinical study of bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for Chinese patients with metastatic colorectal cancer vol.32, pp.1, 2015,
  6. Incidence trends and age distribution of colorectal cancer by subsite in Guangzhou, 2000–2011 vol.34, pp.3, 2015,
  7. Effect of Raf kinase inhibitor protein expression on malignant biological behavior and progression of colorectal cancer vol.34, pp.4, 2015,
  8. Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients vol.36, pp.11, 2015,
  9. Long non-coding RNA LINC01296 is a potential prognostic biomarker in patients with colorectal cancer vol.36, pp.9, 2015,
  10. A Study on the Mechanism of Low-Expressed Cancer Stem Cell Marker Lgr5 in Inhibition of the Proliferation and Invasion of Colorectal Carcinoma vol.73, pp.2, 2015,
  11. Prognostic factors in the patients with T2N0M0 colorectal cancer vol.14, pp.1, 2016,
  12. Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance vol.37, pp.1, 2016,
  13. microRNA -140-5p inhibits colorectal cancer invasion and metastasis by targeting ADAMTS5 and IGFBP5 vol.7, pp.1, 2016,
  14. The association between dietary protein intake and colorectal cancer risk: a meta-analysis vol.15, pp.1, 2017,
  15. Downregulation of microRNA-30d promotes cell proliferation and invasion by targeting LRH-1 in colorectal carcinoma vol.39, pp.6, 2017,
  16. Metabolomics approach for predicting response to neoadjuvant chemotherapy for colorectal cancer vol.14, pp.9, 2018,
  17. genotyping for preventing FOLFIRI-induced severe neutropenia in Chinese colorectal cancer patients pp.1744-8042, 2019,
  18. Risk factors for early postoperative cognitive dysfunction after colorectal surgery vol.19, pp.1, 2019,
  19. Trends in and Predictions of Colorectal Cancer Incidence and Mortality in China From 1990 to 2025 vol.9, pp.2234-943X, 2019,
  20. CHST7 Gene Methylation and Sex-Specific Effects on Colorectal Cancer Risk pp.1573-2568, 2019,